PRA International Achieves Highest Accreditation in Medidata CRO Program
New York, NY and Raleigh, NC
Medidata Solutions,, a global provider of hosted clinical development solutions, announced that PRA International, a global clinical research organization (CRO), has achieved Rave Accredited Plus status in the ASPire to Win® program for CROs and other service providers. The highest achievable tier in the program, Rave Accredited Plus enables PRA to independently offer its customers a full suite of services around the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) platform, including end-user training, study build, reporting, outputs, integrations and migrations.
A full-service contract research organization (CRO) with more than 3,100 global employees, PRA International conducts clinical trials in more than 75 countries across six continents and provides services through all phases of clinical development. PRA has extensive experience delivering more than 150 EDC trials across six continents and started working with Medidata in 2000 as one of Medidata’s first CRO go-to-market partners. PRA formalized its partnership through the ASPire to Win program in 2008. This latest accreditation brings PRA to 18 fully trained Rave database developers, helping PRA’s ability to support its clients’ EDC needs around the globe.
“Achieving the Rave Accredited Plus status in the Medidata partner program gives us a substantial number of staff members with Rave expertise and allows us to deliver key EDC service offerings to our sponsors,” said Mary Mattes, Executive Director of Data Management at PRA International.
“PRA’s accreditation and the expansion of its Medidata Rave-trained team will enable PRA to respond to sponsor demand for Medidata Rave and continue to grow its global customer base,” said Graham Bunn, Vice President of Global CRO Partnerships at Medidata Solutions.
Medidata first announced ASPire to Win in April 2005 as a partner program designed to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, ASPire to Win has grown to include more than 20 partners, ranging from smaller clinical consultancies to large, global CROs. The program offers the choice of four enablement levels – Rave Aware, Rave Ready, Rave Accredited and Rave Accredited Plus.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
